研发核心

汪小莞博士

Xiaowan Wang,Ph.D

个人简介

2011年获东北师范大学生物技术学士学位,2017年获东北师范大学细胞生物学博士学位,2018年加入西湖大学许田团队,历任助理研究员、博士后研究员和副研究员。研究方向为神经损伤与再生的机制和高级认知行为的神经生物学筛选。擅长小鼠各类手术及显微操作,包括但不限于:脑定点注射、胚胎脑定点区域神经元原代培养、DRG神经元体外培养,DRG电转、视网膜及视神经显微操作、坐骨神经损伤造模及肠系膜上动脉夹闭等。

汪小莞

研究内容

致力于推动叶酸代谢诊补一体化产业链条和信息化平台建设。

代表文章

1. Xiaowan Wang, Runmin Song, Wenliang Lu, Ziyu Liu, Lichun Wang, Xiaojuan Zhu, Yanjun Liu, Zijie Sun, Jiang Li and Xiaomeng Li. YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice. Front. Aging Neurosci. (2017). 9: 157.

2. Wei Qiao, Xiaowan Wang, Xiaochun Li, Jiang Li, Xiaomeng Li, Advances in broad-spectrum antitumor effect of four sesquiterpenoids. Chinese Journal of Biochemical Pharmaceutics (2016). 36(3): 5-8.

3. Wei Qiao, Jun Di, Xiaowan Wang, Jiaxin Sun, Qi Zhang, Jiang Li, Xiaomeng Li. Study on functions and mechanisms of Weibimei in inducing gastric cancer cell apoptosis. Chinese Journal of Biochemical Pharmaceutics (2016). 36(7): 15-18.

4. Wei Qiao, Jun Di, Xiaowan Wang, Xu Dong, Qi Zhang, Chunwa Jiang, Jiang Li, Xiaomeng Li. Effects of Chinese medicine portions of Weibimei on cell cycle regulation and tumor inhibition in nude mice. Chinese Journal of Biochemical Pharmaceutics (2016). 36(6): 25-29.

5. Azhar Rasul, Jinmei Liu, Ying Liu, Faya Martin Millimouno, Xiaowan Wang, Ichiro Tsuji, Takaki Yamamura, Jiang Li, Xiaomeng Li. Eriocalyxin B inhibits proliferation and induces apoptosis through downregulation of Bcl-2 and activation of caspase-3 in human bladder cancer cells. B J Pharmacol. (2013). 8:116-123.